Recently, Yiran Biotechnology and Jiangnan University jointly established a collaborative laboratory, with an investment plan of RMB 30 million (approximately USD 4.14 million), focusing on research into “Probiotics + Food-Medicine Homology” technologies. The two parties aim to jointly formulate industry standards, develop precision formulas targeting diseases such as diabetes and depression, and leverage AI technology to accelerate product development. (Source: Yiran Biotechnology)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE